Pauline T Velasco

Title: Pauline T Velasco: Innovator in Monoclonal Antibodies

Introduction

Pauline T Velasco is a notable inventor based in Wilmette, IL (US). She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. Her work focuses on addressing critical challenges in Alzheimer's Disease.

Latest Patents

Pauline holds a patent for "Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)." This patent discloses antibodies that bind with high specificity to soluble oligomers of amyloid β. These antibodies are capable of distinguishing between Alzheimer's Disease (AD) and control human brain extracts. They identify endogenous Abeta oligomers in AD brain slices and bind to Abeta oligomers on cultured hippocampal cells. Furthermore, these antibodies neutralize endogenous Abeta oligomers and those produced in solution. She has 1 patent to her name.

Career Highlights

Throughout her career, Pauline has worked with prominent organizations such as Acumen Pharmaceuticals, Inc. and Northwestern University. Her research has contributed to advancements in understanding and potentially treating Alzheimer's Disease.

Collaborations

Pauline has collaborated with esteemed colleagues, including Sara J Fernandez and Kirsten L Viola. These partnerships have enhanced her research and broadened the impact of her work.

Conclusion

Pauline T Velasco is a pioneering inventor whose work in monoclonal antibodies is making strides in the fight against Alzheimer's Disease. Her innovative research continues to inspire advancements in the biomedical field.